ОЦЕНКА ПРОГНОСТИЧЕСКОГО ЗНАЧЕНИЯ КЛЕТОЧНОЙ ПРОЛИФЕРАЦИИ В МЕЛАНОМЕ КОЖИ ПО ДАННЫМ ИММУНОГИСТОХИМИЧЕСКОГО ИССЛЕДОВАНИЯ
Аннотация
По данным иммуногистохимического исследования проанализирован клеточный пролиферативный индекс при меланоме кожи. Показано отсутствие его зависимости от стадии инвазивного роста по Кларку, толщины опухоли по Breslow, распространённости (рТ) и гистологического типа новообразования.Литература
World Health Organization Classification of Tumours. Pathology & Genetics Skin Tumours / Ph.E. LeBoit [et al.] - Lyon: IARC press, 2006. - P. 64-65.
Gerdes, J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies / J. Gerdes // Semin. Cancer Biol. - 1990. - Vol. 1(3). - P. 199-206.
Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma / S. Ilmonen [et al.] // Melanoma Res. - 2005. - Vol. 15(5). - P. 81-375.
Cell proliferation markers in predicting metastases in malignant melanoma / V.B. Reddy [et al.] // J. Cutan. Pathol. - 1995. - Vol. 22(3). - P. 51-248.
Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma / O. Ben-Izhak [et al.] // Histopathology. - 2002. - Vol. 41(6). - P. 25-519.
Ki67 antigen as a predictive factor for prognosis of sinonasal mucosal melanoma / D.K. Kim [et al.] // Clin. Exp. Otorhinolaryngol. - 2008. - Vol. 1(4) - P. 10-206.
Krvavica, A. Expression of bcl-2, Ki-67 and p-53 in uveal melanomas / A. Krvavica, J. Talan-Hranilovic, M. Belicza // Acta Med. Croatica. - 2008. - Vol. 62(3) - P. 71-267.
MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma / C. Laprie [et al.] // Vet. Dermatol. - 2001. - Vol. 12(3) - P. 47-139.
Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study / S. Moretti [et al.] // J. Invest. Dermatol. - 1990. - Vol. 95(3) - P. 4320.
Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions / S. Moretti [et al.] // J. Am. Acad. Dermatol. -2001. - Vol. 44(2) - P. 92-188.
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome / V.A. Florenes [et al.] / / J. Pathol. - 2001. - Vol. 195(5) - P. 6-530.
McNutt, N.S. «Triggered trap»: nevoid malignant melanoma / N.S. McNutt // Semin. Diagn. Pathol. - 1998. - Vol. 15(3) - P. 9203
Nasr, M.R. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions / M.R. Nasr, O. El-Zammar // Am. J. Dermatopathol. - 2008. - Vol. 30(2) - P. 22-117
Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions / M. Korabiowska [et al.] // In Vivo. - 1995 - Vol. 9(5) - P. 8-433.
A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions / L.X. Li [et al.] // Am. J. Dermatopathol. - 2000. - Vol. 22(6) - P. 489-95.
